NeuMoDx Molecular Systems
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NeuMoDx Molecular Systems
Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.
Qiagen has secured funding from a US government agency to develop a new test kit for COVID-19.
Mayo Clinic is developing a test to detect COVID-19 in the US.
NeuMoDx Molecular announced plans to develop a coronavirus test for its own high-throughput molecular diagnostics platform.
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.